Feldberg, L.; Zvi, A.; Yahalom-Ronen, Y.; Schuster, O. Discriminative Identification of SARS-CoV-2 Variants Based on Mass-Spectrometry Analysis. Biomedicines 2023, 11, 2373, doi:10.3390/biomedicines11092373.
Feldberg, L.; Zvi, A.; Yahalom-Ronen, Y.; Schuster, O. Discriminative Identification of SARS-CoV-2 Variants Based on Mass-Spectrometry Analysis. Biomedicines 2023, 11, 2373, doi:10.3390/biomedicines11092373.
Feldberg, L.; Zvi, A.; Yahalom-Ronen, Y.; Schuster, O. Discriminative Identification of SARS-CoV-2 Variants Based on Mass-Spectrometry Analysis. Biomedicines 2023, 11, 2373, doi:10.3390/biomedicines11092373.
Feldberg, L.; Zvi, A.; Yahalom-Ronen, Y.; Schuster, O. Discriminative Identification of SARS-CoV-2 Variants Based on Mass-Spectrometry Analysis. Biomedicines 2023, 11, 2373, doi:10.3390/biomedicines11092373.
Abstract
The spread of SARS-CoV-2 variants of concern (VOCs), is of great importance to the whole community, since their genetic changes may increase transmissibility, disease severity and reduce effectiveness of vaccines. Moreover, these changes may lead to failure of diagnostic measures, thus variant-specific diagnostic methods are essential. To date, genetic sequencing is the gold standard method to discriminate between variants, however it is time consuming (several days) and expensive. Therefore, the development of rapid diagnostic methods for SARS-CoV-2 in accordance with its genetic modification is of great importance. In this study, we introduce a Mass-Spectrometry (MS)-based methodology for the diagnosis of SARS-CoV-2 in clinical specimens, a methodology which enables universal identification, alongside with variant-specific discrimination. The universal identification of SARS-CoV-2 is based on conserved markers shared by all variants, while the identification of the specific variant relies on variant-specific markers. Determining a specific set of peptides for a given variant consists of a multistep procedure, starting with in-silico search for variant-specific tryptic peptides, followed by tryptic digest of a cell-cultured SARS-CoV-2 variant and identification of these markers by HR-LC-MS/MS analysis. As a proof of concept, this approach was demonstrated for four representative VOCs, in comparison with the wild-type Wuhan reference strain. For each variant, at least two unique markers, derived mainly from the spike (S) and nucleocapsid (N) viral proteins, were identified. This methodology is specific, rapid, easy to perform and inexpensive, therefore can be applied as a general diagnostic tool of pathogenic variants.
Keywords
COVID19; SARS-CoV-2; Variants of Concern; Diagnosis; LC-MS/MS; Mass-Spectrometry; Spike; Nucleocapsid
Subject
Biology and Life Sciences, Virology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
